This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayhan, W. G. Search for Related Content PubMed PubMed Citation Articles by Mayhan, W. G.

Stroke, Vol 25, 141-146, Copyright © 1994 by American Heart Association

ARTICLES

Responses of cerebral arterioles to activation of beta-adrenergic receptors during diabetes mellitus

WG Mayhan
Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha 68198-4575.

BACKGROUND AND PURPOSE--Diabetes mellitus impairs reactivity of large peripheral arteries and arterioles to activation of beta-adrenergic receptors. The goal of this study was to determine whether diabetes mellitus alters dilatation of cerebral arterioles to activation of beta- adrenergic receptors. METHODS--In vivo diameter of pial arterioles was measured in nondiabetic and diabetic (streptozotocin 50 to 60 mg/kg IP) rats during superfusion with isoproterenol, forskolin, and nitroglycerin. In addition, we examined the contribution of nitric oxide or a nitric oxide-containing compound in dilatation of pial arterioles in response to the agonists. RESULTS--Dilatation of pial arterioles in response to isoproterenol was significantly less in diabetic compared with nondiabetic rats (3 +/- 2% versus 14 +/- 1%, respectively, for 1.0 mumol/L isoproterenol). In contrast, dilatation of pial arterioles in response to nitroglycerin and forskolin was similar in nondiabetic and diabetic rats. Furthermore, dilatation of pial arterioles in nondiabetic rats in response to isoproterenol and forskolin was not related to the synthesis and release of nitric oxide or a nitric oxide-containing compound. CONCLUSIONS--The findings of the present studies suggest that diabetes mellitus impairs dilatation of cerebral resistance arterioles in response to activation of beta- adrenergic receptors. Impairment of beta-adrenergic-mediated dilatation of cerebral arterioles during diabetes mellitus does not appear to be related to an alteration in cyclic adenosine monophosphate, since forskolin produced similar vasodilatation in nondiabetic and diabetic rats.

This article has been cited by other articles:

				K. Y. Lee, Y. H. Sohn, J. S. Baik, G. W. Kim, and J.-S. Kim Arterial Pulsatility as an Index of Cerebral Microangiopathy in Diabetes Stroke, May 1, 2000; 31(5): 1111 - 1115. [Abstract] [Full Text] [PDF]

				T. Van Buren, C. M. Kasbergen, W. H. Gispen, and D. J. De Wildt In vivo cardiovascular reactivity and baroreflex activity in diabetic rats Cardiovasc Res, June 1, 1998; 38(3): 763 - 771. [Abstract] [Full Text] [PDF]

				F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]